The ProtecT trial: Analysis of the patient cohort, baseline risk stratification and disease progression
<p><strong>Objective:</strong><br /> To test the hypothesis that the baseline clinico‐pathological features of the men with localized prostate cancer (PCa) included in the ProtecT (Prostate Testing for Cancer and Treatment) trial who progressed (n = 198) at a 10‐year median f...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
其他作者: | |
格式: | Journal article |
语言: | English |
出版: |
Wiley
2020
|